We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-4.23%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$279B
AUM Growth
-$8.2B
Cap. Flow
+$8.77B
Cap. Flow %
3.14%
Top 10 Hldgs %
16.93%
Holding
3,614
New
79
Increased
2,461
Reduced
704
Closed
105

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$441M
2
AVGO icon
Broadcom
AVGO
+$328M
3
PFE icon
Pfizer
PFE
+$292M
4
TSLA icon
Tesla
TSLA
+$252M
5
IBM icon
IBM
IBM
+$209M

Sector Composition

Rank Sector Weight
1 Technology 19.91%
2 Financials 13.22%
3 Healthcare 13.19%
4 Consumer Discretionary 10.07%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HALL
3501
DELISTED
Hallmark Financial Services, Inc.
HALL
$13K ﹤0.01%
1,236
SURF
3502
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$13K ﹤0.01%
12,172
SABS icon
3503
SAB Biotherapeutics
SABS
$272M
$12K ﹤0.01%
1,624
NBSE
3504
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$12K ﹤0.01%
1,486
DMK
3505
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$12K ﹤0.01%
804
RTB
3506
RTB Digital
RTB
$226M
$11K ﹤0.01%
30
MDVL
3507
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$10K ﹤0.01%
238
ADIL
3508
Adial Pharmaceuticals
ADIL
$7.2M
-34
Closed -$29K
ALGS icon
3509
Aligos Therapeutics
ALGS
$26.7M
-2,959
Closed -$90K
AVTX icon
3510
Avalo Therapeutics
AVTX
$1.03B
-20
Closed -$29K
BDTX icon
3511
Black Diamond Therapeutics
BDTX
$98.6M
-17,994
Closed -$45K
BYRN icon
3512
Byrna Technologies
BYRN
$103M
-68,983
Closed -$593K
CAPR icon
3513
Capricor Therapeutics
CAPR
$243M
-14,832
Closed -$52K
CLNN icon
3514
Clene
CLNN
$64.4M
-4,837
Closed -$244K
CMCT
3515
Creative Media & Community Trust
CMCT
$10.1M
0
-$72K
DAVE icon
3516
Dave Inc
DAVE
$4.8B
-25,606
Closed -$564K
EARN
3517
Ellington Residential Mortgage REIT
EARN
$168M
-10,721
Closed -$81K
EDU icon
3518
New Oriental
EDU
$9B
-182,825
Closed -$3.72M
ELMD icon
3519
Electromed
ELMD
$333M
-47,832
Closed -$462K
EMB icon
3520
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
-171,944
Closed -$14.7M
EPSN icon
3521
Epsilon Energy
EPSN
$166M
-12,479
Closed -$74K
FLUX icon
3522
Flux Power
FLUX
$11.5M
-11,565
Closed -$28K
GAN
3523
DELISTED
GAN Ltd
GAN
-174,481
Closed -$517K
CBIO
3524
Crescent Biopharma
CBIO
$555M
-604
Closed -$37K
GSIT icon
3525
GSI Technology
GSIT
$224M
-17,469
Closed -$61K

Similar funds

Charles Schwab's Q3 2022 Portfolio in Review

As of Q3 2022, Charles Schwab held 3,614 positions worth $279B, down 2.9% from $287B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab deployed $8.77B of net new capital in Q3 2022, opening 79 new positions and adding to 2,461 existing holdings. Its largest new stake was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $295M trimmed.

  • Charles Schwab's largest Q3 2022 buy was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
  • Charles Schwab added most to Verizon in Q3 2022, an estimated $441M increase.
  • Charles Schwab's biggest Q3 2022 reduction was iShares National Muni Bond ETF, cutting an estimated $295M.
  • Charles Schwab fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $91.4M.
  • Charles Schwab's ten largest holdings make up 17% of its $279B portfolio in Q3 2022.
  • Charles Schwab opened 79 new positions and closed 105 in Q3 2022.
  • Charles Schwab's portfolio value fell 2.9% quarter-over-quarter to $279B.

Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.